{"id":"W2808047733","doi":"10.1186/s13063-018-2720-6","title":"A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma","year":2018,"lang":"en","type":"article","venue":"Trials","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Energy; University of Calgary","funders":"Alberta Innovates - Health Solutions; Calgary Laboratory Services; University of Calgary; Pfizer","keywords":"Medicine; Bronchodilator; Tolerability; Bronchoconstriction; Asthma; Crossover study; Placebo; Spirometry; Anesthesia; Adverse effect; Bronchodilator Agents; Inhalation; Randomized controlled trial; Allergen; Internal medicine; Allergy; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02849045,0.000405944,0.007753255,0.0004201213,0.00008701978,0.00002865123,0.0004408193,0.0005642439,0.0005109495],"category_scores_gemma":[0.04691694,0.0002886825,0.002226137,0.0004670186,0.001430532,0.0001640411,0.0001250003,0.0004343459,0.00001511436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001187793,"about_ca_system_score_gemma":0.004157565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000105398,"about_ca_topic_score_gemma":0.0000193101,"domain_scores_codex":[0.9881166,0.002139599,0.006957135,0.0007007346,0.001337762,0.0007481936],"domain_scores_gemma":[0.9758695,0.01696386,0.00382155,0.001059112,0.0014847,0.0008012337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8904507,0.003309438,0.000002450669,0.0004320239,0.001795139,0.000009614532,0.0002459833,9.898274e-7,0.008210718,0.0003447333,0.002586429,0.09261184],"study_design_scores_gemma":[0.8319225,0.02799889,5.684446e-7,0.0002745079,0.001355388,0.000006218118,0.00002094789,0.0002031153,0.1182999,0.0002795497,0.01947261,0.000165858],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9129331,0.003667632,0.005425746,0.001074654,0.002678534,0.07283135,0.0004281977,0.00005986545,0.0009009688],"genre_scores_gemma":[0.9718,0.0002164293,0.008015227,0.0005935911,0.01060032,0.002900532,0.00008630793,0.0001881281,0.005599505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1100891,"threshold_uncertainty_score":0.9999565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3395700799792805,"score_gpt":0.5497289902983158,"score_spread":0.2101589103190353,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}